Sfoglia per Autore
Zinc supplementation improves glucose disposal in patients with cirrhosis.
1998-01-01 MARCHESINI G; E. BUGIANESI; RONCHI M; FLAMIA R; THOMASETH K; PACINI G
Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance.
1999-01-01 MARCHESINI G; RONCHI M; FORLANI G; E. BUGIANESI; BIANCHI G; FABBRI A; ZOLI M; MELCHIONDA N
Association of nonalcoholic fatty liver disease with insulin resistance.
1999-01-01 MARCHESINI G; BRIZI M; MORSELLI-LABATE AM; BIANCHI G; E. BUGIANESI; MCCULLOUGH AJ; FORLANI G; MELCHIONDA N
Insulin resistance is an independent defect in non-alcoholic steatohepatitis (NASH).
2001-01-01 E. Vanni; E. Bugianesi; A. Gastaldelli; R. Gambino; M. Cassader; V. Ponti; E. Ferranninni; G. Pagano; M. Rizzetto
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
2001-01-01 MARCHESINI G; BRIZI M; BIANCHI G; TOMASSETTI S; E. BUGIANESI; LENZI M; MCCULLOUGH AJ; NATALE S; FORLANI G; MELCHIONDA N
Does nonalcoholic steatohepatitis (NASH) progress to cryptogenic cirrhosis (CC) and hepatocellular carcinoma (HCC) - A case-control study.
2001-01-01 N. Leone; E. Bugianesi; F. Brunello; P. Carucci; E. Vanni; G.M. Reggiani; A. Musso; A. Muratore; P. De Paolis; L. Capussotti; M. Salizzoni; M.
A new mutation of the apolipoprotein B gene originates the apo B32,4 truncated protein.
2002-01-01 Guardamagna O; Bugianesi E; Bonardi R; Molini V; Bondone C; Bobbio A;
Impaired lipid transport due to heterozygous hypobetalipoproteinemia.
2002-01-01 Allora C; Bugianesi E; Molini V; Bondone C; Bonardi R; Guardamagna O.
Increased LDL-cholesterol susceptibility to oxidation contributes to oxidative damage in non alcoholic steatohepadtis (NASH).
2002-01-01 E. Vanni; E. Bugianesi; N. Leone; S. Baid; R. Gambino; M. Cassader; E. Ferrannini; M. Rizzetto.
Familial hypobetalipoproteinemia and liver steatosis.
2002-01-01 Allora C; Molini V; Bugianesi E; Rabbone I; Bondone C; Bonardi R; Guardamagna O.
Increased LDL-cholesterol susceptibility to oxidation contributes to oxidative damage in non alcoholic steatohepatitis (NASH).
2002-01-01 E. Vanni; E. Bugianesi; S. Baldi; N. Leone; R. Gambino; M. Cassader; E. Ferrannini; M. Rizzetto.
Abnormal insulin sensitivity in-chronic hepatitis C virus (HCV) infection: A link with steatosis?
2002-01-01 Bugianesi E; Vanni E; Gastaldelli A; Abate ML; Hickman I; Gambino R; Cassader M; Smedile A; Ferrannini E; Rizzetto M
Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
2002-01-01 E. Bugianesi; N. Leone; E. Vanni; G. Marchesini; F. Brunello; P. Carucci; A. Musso; P. De Paolis; L. Capussotti; M. Salizzoni; M. Rizzetto
Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance
2003-01-01 MARCHESINI G; PAGOTTO U; E. BUGIANESI; DE IASIO R; MANINI R; VANNI E; PASQUALI R; MELCHIONDA N; RIZZETTO M
Ghrelin in non-alcoholic fatty liver disease
2003-01-01 E. Bugianesi;G. Marchesini;U. Pagotto;R. Manini;E. Vanni;R. De Iasio;R. Pasquali;N. Melchionda;M. Rizzetto
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
2003-01-01 G. MARCHESINI; E. BUGIANESI; G. FORLANI; F. CERRELLI; M. LENZI; R. MANINI; S. NATALE; E. VANNI; N. VILLANOVA; N. MELCHIONDA; M. RIZZETTO
Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and HCV chronic hepatitis
2004-01-01 E. Bugianesi; E. Vanni; A. Gastaldelli; E. Gentilcore; R. Gambino; B. Uberti; M. Cassader ; G. Pagano; E. Ferrannini; M. Rizzetto.
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
2004-01-01 BUGIANESI E; MARZOCCHI R; VILLANOVA N; MARCHESINI G
Metformin (MET) vs. diet in Non Alcoholic Fatty Liver Disease (NAFLD): a randomized controlled clinical trial
2004-01-01 E. Gentilcore; E. Bugianesi; G. Marchesini; E. Vanni; R. Marzocchi; M. Rizzetto
Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?
2004-01-01 BUGIANESI E; ZANNONI C; VANNI E; MARZOCCHI R; MARCHESINI G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Zinc supplementation improves glucose disposal in patients with cirrhosis. | 1998 | MARCHESINI G; E. BUGIANESI; RONCHI M; FLAMIA R; THOMASETH K; PACINI G | |
| Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance. | 1999 | MARCHESINI G; RONCHI M; FORLANI G; E. BUGIANESI; BIANCHI G; FABBRI A; ZOLI M; MELCHIONDA N | |
| Association of nonalcoholic fatty liver disease with insulin resistance. | 1999 | MARCHESINI G; BRIZI M; MORSELLI-LABATE AM; BIANCHI G; E. BUGIANESI; MCCULLOUGH AJ; FORLANI G; MELCHIONDA N | |
| Insulin resistance is an independent defect in non-alcoholic steatohepatitis (NASH). | 2001 | E. Vanni; E. Bugianesi; A. Gastaldelli; R. Gambino; M. Cassader; V. Ponti; E. Ferranninni; G. Pagano; M. Rizzetto | |
| Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. | 2001 | MARCHESINI G; BRIZI M; BIANCHI G; TOMASSETTI S; E. BUGIANESI; LENZI M; MCCULLOUGH AJ; NATALE S; FORLANI G; MELCHIONDA N | |
| Does nonalcoholic steatohepatitis (NASH) progress to cryptogenic cirrhosis (CC) and hepatocellular carcinoma (HCC) - A case-control study. | 2001 | N. Leone; E. Bugianesi; F. Brunello; P. Carucci; E. Vanni; G.M. Reggiani; A. Musso; A. Muratore; P. De Paolis; L. Capussotti; M. Salizzoni; M. | |
| A new mutation of the apolipoprotein B gene originates the apo B32,4 truncated protein. | 2002 | Guardamagna O; Bugianesi E; Bonardi R; Molini V; Bondone C; Bobbio A; | |
| Impaired lipid transport due to heterozygous hypobetalipoproteinemia. | 2002 | Allora C; Bugianesi E; Molini V; Bondone C; Bonardi R; Guardamagna O. | |
| Increased LDL-cholesterol susceptibility to oxidation contributes to oxidative damage in non alcoholic steatohepadtis (NASH). | 2002 | E. Vanni; E. Bugianesi; N. Leone; S. Baid; R. Gambino; M. Cassader; E. Ferrannini; M. Rizzetto. | |
| Familial hypobetalipoproteinemia and liver steatosis. | 2002 | Allora C; Molini V; Bugianesi E; Rabbone I; Bondone C; Bonardi R; Guardamagna O. | |
| Increased LDL-cholesterol susceptibility to oxidation contributes to oxidative damage in non alcoholic steatohepatitis (NASH). | 2002 | E. Vanni; E. Bugianesi; S. Baldi; N. Leone; R. Gambino; M. Cassader; E. Ferrannini; M. Rizzetto. | |
| Abnormal insulin sensitivity in-chronic hepatitis C virus (HCV) infection: A link with steatosis? | 2002 | Bugianesi E; Vanni E; Gastaldelli A; Abate ML; Hickman I; Gambino R; Cassader M; Smedile A; Ferrannini E; Rizzetto M | |
| Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma | 2002 | E. Bugianesi; N. Leone; E. Vanni; G. Marchesini; F. Brunello; P. Carucci; A. Musso; P. De Paolis; L. Capussotti; M. Salizzoni; M. Rizzetto | |
| Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance | 2003 | MARCHESINI G; PAGOTTO U; E. BUGIANESI; DE IASIO R; MANINI R; VANNI E; PASQUALI R; MELCHIONDA N; RIZZETTO M | |
| Ghrelin in non-alcoholic fatty liver disease | 2003 | E. Bugianesi;G. Marchesini;U. Pagotto;R. Manini;E. Vanni;R. De Iasio;R. Pasquali;N. Melchionda;M. Rizzetto | |
| Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. | 2003 | G. MARCHESINI; E. BUGIANESI; G. FORLANI; F. CERRELLI; M. LENZI; R. MANINI; S. NATALE; E. VANNI; N. VILLANOVA; N. MELCHIONDA; M. RIZZETTO | |
| Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and HCV chronic hepatitis | 2004 | E. Bugianesi; E. Vanni; A. Gastaldelli; E. Gentilcore; R. Gambino; B. Uberti; M. Cassader ; G. Pagano; E. Ferrannini; M. Rizzetto. | |
| Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment | 2004 | BUGIANESI E; MARZOCCHI R; VILLANOVA N; MARCHESINI G | |
| Metformin (MET) vs. diet in Non Alcoholic Fatty Liver Disease (NAFLD): a randomized controlled clinical trial | 2004 | E. Gentilcore; E. Bugianesi; G. Marchesini; E. Vanni; R. Marzocchi; M. Rizzetto | |
| Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? | 2004 | BUGIANESI E; ZANNONI C; VANNI E; MARZOCCHI R; MARCHESINI G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile